Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1978 Jul 29;2(6133):322–324. doi: 10.1136/bmj.2.6133.322

Heparin-like activity in uterine fluid.

M E Foley, B D Griffin, M Zuzel, S R Aparicio, K Bradbury, C C Bird, J K Clayton, D M Jenkins, J S Scott, S M Rajah, G P McNichol
PMCID: PMC1606443  PMID: 687899

Abstract

Uterine fluid was collected from a group of normal patients and a group of patients with menorrhagia. Heparin-like activity was detected in 34 out of 38 samples using an anti-Xa heparin assay. The heparin-like activity in uterine fluid was inhibited by adding the heparin antagonist hexadimethrine bromide to the assay. Concentrations of fibrinogen-fibrin degradation products (FDPs) were measured in five samples of uterine fluid. FDPs in the concentration detected had no effect on the anti-Xa assay. Heparin-like activity was higher in the group with menorrhagia, although the differences were not significant. Heparin-like activity increased throughout the menstrual cycle and decreased during menstruation, suggesting a possible cyclical variation in activity. There was no correlation between mast cell numbers in the endometrium and myometrium and heparin-like activity in uterine fluid and no correlation between the numbers and the stage in the menstrual cycle. In a few patients with intrauterine contraceptive devices (IUCDs) heparin-like activity was increased.

Full text

PDF
322

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BENSLEY S. H. Pinacyanol erthrosinate as a stain for mast cells. Stain Technol. 1952 Sep;27(5):269–273. doi: 10.3109/10520295209105090. [DOI] [PubMed] [Google Scholar]
  2. Cooper B. S., Hawk H. W. Effect of intrauterine devices on endometrial mucopolysaccharides in the cow. Fertil Steril. 1968 Mar-Apr;19(2):310–316. doi: 10.1016/s0015-0282(16)36616-x. [DOI] [PubMed] [Google Scholar]
  3. Denson K. W., Bonnar J. The measurement of heparin. A method based on the potentiation of anti-factor Xa. Thromb Diath Haemorrh. 1973 Dec 31;30(3):471–479. [PubMed] [Google Scholar]
  4. Jaques L. B., Mahadoo J., Riley J. F. The mast cell/heparin paradox. Lancet. 1977 Feb 19;1(8008):411–413. doi: 10.1016/s0140-6736(77)92615-0. [DOI] [PubMed] [Google Scholar]
  5. Mathur V. S., Chaudhury R. R. The effect of an intra-uterine plastic device on the mast cell count in the rat uterus. J Reprod Fertil. 1968 Feb;15(1):135–138. doi: 10.1530/jrf.0.0150135. [DOI] [PubMed] [Google Scholar]
  6. Mehra U., Devi P. K., Chakravarti R. N., Chaudhury R. R. The relationship between endometrial mast cell count and bleeding in women following insertion of an intrauterine device. Am J Obstet Gynecol. 1970 Jul 15;107(6):852–856. doi: 10.1016/s0002-9378(16)34036-4. [DOI] [PubMed] [Google Scholar]
  7. VARA P. [On the function of the mast cells in the endometrium and their role in the noncoagulability of menstrual blood]. Geburtshilfe Frauenheilkd. 1962 Oct;22:989–992. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES